Annual D&A
$461.30K$141.70K+44.34%
Summary
- Current Value
- As of today, OCS annual D&A is $461.30K, up +44.34% on
- Historical Performance
- OCS annual D&A is up +79.42% over the past 3 years, and up +89.68% over the past 5 years
- All-Time High Comparison
- OCS annual D&A is currently at its all-time high
- 3-Year Low Comparison
- OCS annual D&A is +47.15% above its 3-year low of $313.50K reached on an earlier date
- Sector Comparison
- OCS annual D&A is higher than 28.16% of companies in Healthcare sector
Depreciation & Amortization Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual D&A | $461.30K | +44.3% | +79.4% | +89.7% | +89.7% | |
| Quarterly D&A | $198.30K | +37.0% | -13.8% | – | – | |
| TTM D&A | $611.70K | +50.3% | +59.2% | – | – | |
| Price | $20.97 | +15.1% | +108.0% | – | – | |
| Annual SG&A | $21.50M | +31.1% | +379.6% | +473.4% | +473.4% | |
| Annual Total Expenses | $83.17M | +62.9% | +474.5% | +532.1% | +532.1% | |
| Annual Operating Expenses | $83.17M | +62.9% | +474.5% | +532.1% | +532.1% | |
| Annual Revenue | $0.00 | 0.0% | 0.0% | – | – |
Depreciation & Amortization Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $461.30K | at high | |
| 5Y | $461.30K | at high | |
| All | $461.30K | at high |
Depreciation & Amortization Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $313.50K | N/A | +47.1% |
| 5Y | $243.20K | N/A | +89.7% |
| All | $243.20K | +89.7% |
Depreciation & Amortization History
| Year | Value | Change |
|---|---|---|
| $461.30K | +44.3% | |
| $319.60K | +1.9% | |
| $313.50K | +21.9% |
| Year | Value | Change |
|---|---|---|
| $257.10K | +5.7% | |
| $243.20K | - |
FAQ
What is the current annual D&A of OCS?
As of today, OCS annual D&A is $461.30K
What is 1-year change in OCS annual D&A?
OCS annual D&A is up +44.34% year-over-year
What is 3-year change in OCS annual D&A?
OCS annual D&A is up +79.42% over the past 3 years
How far is OCS annual D&A from its all-time high?
OCS annual D&A is currently at its all-time high
How does OCS annual D&A rank versus sector peers?
OCS annual D&A is higher than 28.16% of companies in Healthcare sector
When is OCS next annual earnings release?
The next annual earnings release for OCS is on
Quarterly D&A
$198.30K$50.80K+34.44%
Summary
- Current Value
- As of today, OCS quarterly D&A is $198.30K, up +34.44% on
- Historical Performance
- OCS quarterly D&A is up +37.04% year-over-year, and down -13.75% over the past 3 years
- All-Time High Comparison
- OCS quarterly D&A is currently -13.75% below its historical high of $229.90K set on
- 3-Year Low Comparison
- OCS quarterly D&A is +191.62% above its 3-year low of $68.00K reached on
- Sector Comparison
- OCS quarterly D&A is higher than 35.60% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly D&A | $198.30K | +34.4% | +37.0% | -13.8% | – | |
| Annual D&A | $461.30K | – | +44.3% | +79.4% | +89.7% | |
| TTM D&A | $611.70K | +9.6% | +50.3% | +59.2% | – | |
| Price | $20.97 | +10.0% | +15.1% | +108.0% | – | |
| Quarterly SG&A | $0.00 | -100.0% | -100.0% | 0.0% | -100.0% | |
| Quarterly Total Expenses | $21.06M | -31.4% | -9.6% | – | +8365.8% | |
| Quarterly Operating Expenses | $25.48M | +0.6% | +21.1% | – | +10000.0% | |
| Quarterly Revenue | $0.00 | 0.0% | 0.0% | – | 0.0% |
Quarterly D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $198.30K | at high | |
| 3Y | $198.30K | at high | |
| 5Y | $229.90K | -13.8% | |
| All | $229.90K | -13.8% |
Quarterly D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $129.10K | N/A | +53.6% |
| 3Y | $68.00K | +191.6% | |
| 5Y | $68.00K | +191.6% | |
| All | $68.00K | +191.6% |
Quarterly D&A History
FAQ
What is the current quarterly D&A of OCS?
As of today, OCS quarterly D&A is $198.30K
What is OCS quarterly D&A most recent change?
OCS quarterly D&A was up +34.44% on September 30, 2025
What is 1-year change in OCS quarterly D&A?
OCS quarterly D&A is up +37.04% year-over-year
How far is OCS quarterly D&A from its all-time high?
OCS quarterly D&A is currently -13.75% below its historical high of $229.90K set on September 30, 2022
How does OCS quarterly D&A rank versus sector peers?
OCS quarterly D&A is higher than 35.60% of companies in Healthcare sector
When is OCS next earnings release?
The next earnings release for OCS is on
TTM D&A
$611.70K$53.60K+9.60%
Summary
- Current Value
- As of today, OCS TTM D&A is $611.70K, up +9.60% on
- Historical Performance
- OCS TTM D&A is up +50.33% year-over-year, and up +59.17% over the past 3 years
- All-Time High Comparison
- OCS TTM D&A is currently at its all-time high
- 3-Year Low Comparison
- OCS TTM D&A is +157.02% above its 3-year low of $238.00K reached on
- Sector Comparison
- OCS TTM D&A is higher than 31.03% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM D&A | $611.70K | +9.6% | +50.3% | +59.2% | – | |
| Annual D&A | $461.30K | – | +44.3% | +79.4% | +89.7% | |
| Quarterly D&A | $198.30K | +34.4% | +37.0% | -13.8% | – | |
| Price | $20.97 | +10.0% | +15.1% | +108.0% | – | |
| TTM SG&A | -$1.56B | -6116.0% | -6784.5% | -10000.0% | -10000.0% | |
| TTM Revenue | $0.00 | 0.0% | 0.0% | – | 0.0% |
TTM D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $611.70K | at high | |
| 3Y | $611.70K | at high | |
| 5Y | $611.70K | at high | |
| All | $611.70K | at high |
TTM D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $455.20K | N/A | +34.4% |
| 3Y | $238.00K | +157.0% | |
| 5Y | $198.20K | +208.6% | |
| All | $198.20K | +208.6% |
TTM D&A History
FAQ
What is the current TTM D&A of OCS?
As of today, OCS TTM D&A is $611.70K
What is OCS TTM D&A most recent change?
OCS TTM D&A was up +9.60% on September 30, 2025
What is 1-year change in OCS TTM D&A?
OCS TTM D&A is up +50.33% year-over-year
How far is OCS TTM D&A from its all-time high?
OCS TTM D&A is currently at its all-time high
How does OCS TTM D&A rank versus sector peers?
OCS TTM D&A is higher than 31.03% of companies in Healthcare sector
When is OCS next earnings release?
The next earnings release for OCS is on
Data Sources & References
- OCS Official Website oculis.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1953530/000095017025037224/0000950170-25-037224-index.htm
- OCS Profile on Yahoo Finance finance.yahoo.com/quote/OCS
- OCS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ocs